Anti-DAB2/ DOC-2/ DOC2 monoclonal antibody

Anti-DAB2/ DOC-2/ DOC2 antibody for FACS & in-vivo assay

Target products collectionGo to DAB2/DAB2 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)


Product information

Catalog No.Product NameSpecies Reactivity
GM-Tg-hg-MP2075-Ab-1/ GM-Tg-hg-MP2075-Ab-2Anti-Human DAB2 monoclonal antibodyHuman
GM-Tg-rg-MP2075-Ab-1/ GM-Tg-rg-MP2075-Ab-2Anti-Rat DAB2 monoclonal antibodyRat
GM-Tg-mg-MP2075-Ab-1/ GM-Tg-mg-MP2075-Ab-2Anti-Mouse DAB2 monoclonal antibodyMouse
GM-Tg-cynog-MP2075-Ab-1/ GM-Tg-cynog-MP2075-Ab-2Anti-Cynomolgus/ Rhesus macaque DAB2 monoclonal antibodyCynomolgus/ Rhesus macaque
GM-Tg-felg-MP2075-Ab-1/ GM-Tg-felg-MP2075-Ab-2Anti-Feline DAB2 monoclonal antibodyFeline
GM-Tg-cang-MP2075-Ab-1/ GM-Tg-cang-MP2075-Ab-2Anti-Canine DAB2 monoclonal antibodyCanine
GM-Tg-bovg-MP2075-Ab-1/ GM-Tg-bovg-MP2075-Ab-2Anti-Bovine DAB2 monoclonal antibodyBovine
GM-Tg-equg-MP2075-Ab-1/ GM-Tg-equg-MP2075-Ab-2Anti-Equine DAB2 monoclonal antibodyEquine

Size: 1mg | 10mg | 100mg



Product Description

Catalog No.GM-Tg-hg-MP2075-Ab-1/ GM-Tg-hg-MP2075-Ab-2; GM-Tg-rg-MP2075-Ab-1/ GM-Tg-rg-MP2075-Ab-2;
GM-Tg-mg-MP2075-Ab-1/ GM-Tg-mg-MP2075-Ab-2; GM-Tg-cynog-MP2075-Ab-1/ GM-Tg-cynog-MP2075-Ab-2;
GM-Tg-felg-MP2075-Ab-1/ GM-Tg-felg-MP2075-Ab-2; GM-Tg-cang-MP2075-Ab-1/ GM-Tg-cang-MP2075-Ab-2;
GM-Tg-bovg-MP2075-Ab-1/ GM-Tg-bovg-MP2075-Ab-2; GM-Tg-equg-MP2075-Ab-1/ GM-Tg-equg-MP2075-Ab-2
Products NameAnti-DAB2 monoclonal antibody
Formatmab
Target NameDAB2
Protein Sub-locationTransmembrane Protein
Category of antibodyFACS/Biofunctional Antibody
Derivation (species)Mouse
CH1+2+3 Isotype
(Receptor identification)
IgG
Type of Light Chain (VD-LC)N/A
Expression platformMammalian Expression
Bioactivity validationBinding affinity is validated by using flow cytometry with antigen overexpressed cell line. The biofunction of antibodies are validated in cell-based assay (IC50 or EC50 TBD).
TagFc
Products descriptionPre-made anti-DAB2 benchmark inhibitory monoclonal antibody(mab) (blocking antibody inhibitor) is expressed by mammalian cell line as a benchmark antibody for cell culture, FACS,ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic)
Purity Purity: ≥95% (SDS-PAGE)
Application Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation Lyophilized from sterile PBS, PH 7.4
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference




    Data / case study


    Click to get more Data / Case study about the product.



    Associated products


    CategoryCat No.Products Name
    Target AntigenProducts DevelopingMulti-species DAB2/ DOC-2/ DOC2 VLP (virus-like particle) (Products Developing)
    ORF Viral VectorpGMAD000123human DAB2 Adenovirus plasmid
    ORF Viral VectorvGMAD000123human DAB2 Adenovirus particle
    ORF Viral VectorpGMLPm003112mouse Dab2 Lentivirus plasmid
    ORF Viral VectorvGMLPm003112mouse Dab2 Lentivirus particle


    Target information

    Target IDGM-MP2075
    Target NameDAB2
    Gene ID1601,13132,79128,694349,479353,101096539,509221,100066655
    Gene Symbol and Synonyms5730435J12Rik,D15Wsu122e,D630005B22Rik,DAB2,DOC-2,DOC2,p96
    Uniprot AccessionP98082,O88797
    Uniprot Entry NameDAB2_HUMAN,DAB2_RAT
    Protein Sub-locationTransmembrane Protein
    Category
    DiseaseCancer
    Gene EnsemblENSG00000153071
    Target ClassificationTumor-associated antigen (TAA)

    The target: DAB2, gene name: DAB2, also named as DOC-2, DOC2. This gene encodes a mitogen-responsive phosphoprotein. It is expressed in normal ovarian epithelial cells, but is down-regulated or absent from ovarian carcinoma cell lines, suggesting its role as a tumor suppressor. This protein binds to the SH3 domains of GRB2, an adaptor protein that couples tyrosine kinase receptors to SOS (a guanine nucleotide exchange factor for Ras), via its C-terminal proline-rich sequences, and may thus modulate growth factor/Ras pathways by competing with SOS for binding to GRB2. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Oct 2011].



    About Gmab

    GDU
    GDU



    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.

    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.